Latest Healthcare It News

The Supreme Court of New South Wales has approved the scheme of arrangement for SDI Limited’s acquisition by Beijing Guoci’s subsidiary, paving the way for a cash payout and ASX suspension.

Kingfish Limited posted a $13.6 million net loss for the year ended 31 March 2026, with portfolio returns lagging the benchmark amid geopolitical tensions and AI sector uncertainty.

Pathkey.AI has finalised its takeover of Chipforge, an AI-driven semiconductor design company, issuing shares and performance rights as consideration. The move broadens Pathkey's AI platform capabilities from clinical trials into semiconductor engineering, aiming to shorten chip development cycles significantly.

Vection Technologies has locked in approximately $2.3 million in new AI-related contracts spanning healthcare, luxury fashion, public services, airport passenger assistance, and security, pushing total orders since April 2026 to around $7 million.

Microba Life Sciences is targeting a $6 million capital raise through a $1 million Securities Purchase Plan and a $5 million Placement, both subject to shareholder approval. The funds aim to accelerate diagnostics growth and develop a new testing product.

Arena REIT's portfolio valuation rises by $11.5 million in H2 FY2026, underpinning a 5.5% increase in distributions and continued active portfolio management.

Arena REIT has declared its June 2026 quarterly distribution at 4.8125 cents per security, consistent with its full-year guidance, and is offering a Dividend Reinvestment Plan with a 1.5% discount to encourage reinvestment.

InteliCare (ASX:ICR) is hitting a commercial inflection point, backed by a landmark $8.8 million contract with mecwacare and a growing pipeline across aged care sectors. Its AI-powered platform promises measurable improvements in care outcomes and operational efficiency.

Charter Hall Social Infrastructure REIT (CQE) has acquired a 25% interest in a $53 million Brisbane pathology lab leased to Sonic Healthcare under a 20-year triple-net lease, while divesting early learning assets and reaffirming FY26 guidance.

Microba Life Sciences secures $5 million in a placement led by Sonic Healthcare to fund its push towards cashflow break-even by 2027, backed by strong diagnostic sales and AI-driven efficiencies.

TruScreen has secured clinical validation from the world’s largest cervical screening study in China, setting the stage for rapid market expansion across Asia, Africa, and Europe.

Kingfish Limited's May update reveals a robust 5.5% portfolio return, driven by standout performances from Fisher & Paykel Healthcare and Infratil amid mixed sector headwinds.